Pharmacogenetics in the management of breast cancer - Prospects for individualised treatment

Fiona H. Blackhall; Sacha Howell; Bill Newman

doi:10.1007/s10689-005-3241-5

Pharmacogenetics in the management of breast cancer - Prospects for individualised treatment

Fiona H. Blackhall, Sacha Howell, Bill Newman

Research output: Contribution to journal › Article › peer-review

Abstract

Increased understanding of how variants in genes encoding metabolising enzymes, transporters and receptors affect drug efficacy and toxicity, in parallel with advances in genotyping technology means that clinical pharmacogenetics is drawing tantalisingly close to reality. This review considers some of the pharmacogenetic variants that have been described that are relevant to the management of women with breast cancer and how these may soon translate into clinical practice. © Springer 2006.

Original language	English
Pages (from-to)	151-157
Number of pages	6
Journal	Familial Cancer
Volume	5
Issue number	2
DOIs	https://doi.org/10.1007/s10689-005-3241-5
Publication status	Published - Jun 2006

Keywords

Breast cancer
Pharmacogenetics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10689-005-3241-5

Cite this

@article{68627ef15ea44e48863fc780465e58e8,

title = "Pharmacogenetics in the management of breast cancer - Prospects for individualised treatment",

abstract = "Increased understanding of how variants in genes encoding metabolising enzymes, transporters and receptors affect drug efficacy and toxicity, in parallel with advances in genotyping technology means that clinical pharmacogenetics is drawing tantalisingly close to reality. This review considers some of the pharmacogenetic variants that have been described that are relevant to the management of women with breast cancer and how these may soon translate into clinical practice. {\textcopyright} Springer 2006.",

keywords = "Breast cancer, Pharmacogenetics",

author = "Blackhall, \{Fiona H.\} and Sacha Howell and Bill Newman",

year = "2006",

month = jun,

doi = "10.1007/s10689-005-3241-5",

language = "English",

volume = "5",

pages = "151--157",

journal = "Familial Cancer",

issn = "1389-9600",

publisher = "Springer Nature",

number = "2",

}

TY - JOUR

T1 - Pharmacogenetics in the management of breast cancer - Prospects for individualised treatment

AU - Blackhall, Fiona H.

AU - Howell, Sacha

AU - Newman, Bill

PY - 2006/6

Y1 - 2006/6

N2 - Increased understanding of how variants in genes encoding metabolising enzymes, transporters and receptors affect drug efficacy and toxicity, in parallel with advances in genotyping technology means that clinical pharmacogenetics is drawing tantalisingly close to reality. This review considers some of the pharmacogenetic variants that have been described that are relevant to the management of women with breast cancer and how these may soon translate into clinical practice. © Springer 2006.

AB - Increased understanding of how variants in genes encoding metabolising enzymes, transporters and receptors affect drug efficacy and toxicity, in parallel with advances in genotyping technology means that clinical pharmacogenetics is drawing tantalisingly close to reality. This review considers some of the pharmacogenetic variants that have been described that are relevant to the management of women with breast cancer and how these may soon translate into clinical practice. © Springer 2006.

KW - Breast cancer

KW - Pharmacogenetics

UR - https://www.scopus.com/pages/publications/33744720112

U2 - 10.1007/s10689-005-3241-5

DO - 10.1007/s10689-005-3241-5

M3 - Article

SN - 1389-9600

VL - 5

SP - 151

EP - 157

JO - Familial Cancer

JF - Familial Cancer

IS - 2

ER -

Pharmacogenetics in the management of breast cancer - Prospects for individualised treatment

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this